The cost of diabetic treatment got reduced from ₹1,350 per month to ₹ 270 a month. What is the reason behind such huge reduction in cost burden? Experts say that the introduction of Teneligliptin, an oral anti-diabetic drug, has made this paradigm shift possible in the antidiabetic market. At last some relief for both diabetologists and patients in India where the cost of diabetes therapy is a real concern.
India is supposed to be the country with one of the highest burdens of diabetes in the world with a projected 109 million individuals with diabetes by 2035. The disease currently affects more than 62 million Indians, which is more than 7.1% of India's adult Population. An estimate shows that nearly 1 million Indians die due to Diabetes every year. The high incidence is attributed to a combination of genetic susceptibility plus adoption of a high-calorie, low-activity lifestyle by…
